CritiTech Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CritiTech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2790
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CritiTech Inc (CritiTech) is a pharmaceutical contract development manufacturing organization that specializes in particle engineering, material characterization, analytical testing, early stage drug development, pre-clinical and clinical manufacturing. The company uses Spray Drying and Supercritical Precipitation to help its customers develop their drugs. It offers contract research services such as particle engineering services, material characterization services, analytical services, and manufacturing services. CritiTech’s bioavailability optimization technology is an advanced and novel approach to the production of nanoparticulate pharmaceuticals. The company collaborates with universities, pharmaceutical companies and bio-research institutes to develop drugs. CritiTech is headquartered in Lawrence, Kansas, the US.

CritiTech Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CritiTech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CritiTech Inc, Medical Devices Deals, 2012 to YTD 2018 9
CritiTech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CritiTech Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Crititech Raises US$1.2 Million In Venture Financing 11
CritiTech Raises Additional USD0.7 Million in Venture Financing 12
CritiTech Raises US$3 Million In Venture Financing 13
Partnerships 14
DFB Pharma, CritiTech and US Biotest Form Joint Venture 14
CritiTech Enters Into Joint Venture With Finoso Pharma 15
CritiTech Inc – Key Competitors 16
CritiTech Inc – Key Employees 17
CritiTech Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
CritiTech Inc, Pharmaceuticals & Healthcare, Key Facts 2
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CritiTech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CritiTech Inc, Deals By Therapy Area, 2012 to YTD 2018 8
CritiTech Inc, Medical Devices Deals, 2012 to YTD 2018 9
CritiTech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Crititech Raises US$1.2 Million In Venture Financing 11
CritiTech Raises Additional USD0.7 Million in Venture Financing 12
CritiTech Raises US$3 Million In Venture Financing 13
DFB Pharma, CritiTech and US Biotest Form Joint Venture 14
CritiTech Enters Into Joint Venture With Finoso Pharma 15
CritiTech Inc, Key Competitors 16
CritiTech Inc, Key Employees 17
CritiTech Inc, Joint Venture 18

List of Figures
CritiTech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CritiTech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CritiTech Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[CritiTech Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Berkley Renewables Inc (BKS):企業の財務・戦略的SWOT分析
    Berkley Renewables Inc (BKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ws Atkins Ltd
    Ws Atkins Ltd - Strategy, SWOT and Corporate Finance Report Summary Ws Atkins Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Orsted AS Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Orsted AS Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Orsted AS (Orsted) formerly Dong Energy A/S, is an integrated energy company that procures, produces, distributes and trades energy and energy related products. It generates electricity and heat using conv …
  • International Flavors & Fragrances Inc.:企業の戦略・SWOT・財務分析
    International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report Summary International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • NeuroLogica Corp:医療機器:M&Aディール及び事業提携情報
    Summary NeuroLogica Corp (NeuroLogica), a subsidiary of Samsung Electronics America Inc is a medical device company that develops, manufactures and markets medical imaging equipment. The company offers digital radiography systems for hospitals and imaging centers, portable CT imaging systems, and ul …
  • Deoleo SA:企業の戦略・SWOT・財務分析
    Deoleo SA - Strategy, SWOT and Corporate Finance Report Summary Deoleo SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Kyushu Financial Group Inc (7180):企業の財務・戦略的SWOT分析
    Kyushu Financial Group Inc (7180) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Re-Vana Therapeutics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Re-Vana Therapeutics Ltd (Re-Vana) is an ocular pharmaceutical and drug delivery company that develops and commercialization of biodegradable long- acting drug delivery platforms to treat ophthalmic conditions. The company provides drug delivery products such as OcuLief, an injectable platfo …
  • Sally Beauty Holdings Inc:企業の戦略・SWOT・財務分析
    Sally Beauty Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Sally Beauty Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Aratana Therapeutics Inc (PETX):企業の財務・戦略的SWOT分析
    Summary Aratana Therapeutics Inc (Aratana) is a provider of pet care solutions. The company develops, commercializing and markets biopharmaceutical products for medical condition in cats and dogs. Its pipeline portfolio consists of small molecule pharmaceuticals and large molecule biologics that aim …
  • U.S. Stem Cell Inc (USRM):企業の財務・戦略的SWOT分析
    U.S. Stem Cell Inc (USRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Healthcare Services Group Inc (HCSG):企業の財務・戦略的SWOT分析
    Healthcare Services Group Inc (HCSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Aibel AS:企業の戦略的SWOT分析
    Aibel AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Kaiser Permanente:企業の戦略・SWOT・財務分析
    Kaiser Permanente - Strategy, SWOT and Corporate Finance Report Summary Kaiser Permanente - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • UbiQ Bio BV-製薬・医療分野:企業M&A・提携分析
    Summary UbiQ Bio BV (UbiQ) is a biotechnology company that develops and commercializes ubiquitinated peptides and assays that enables drug discovery in Ubiquitin field. The company provides products such as ubiquitin-proteasome system, high throughput screening assay reagents and ubiquitinated polyp …
  • CSL Limited:企業の戦略・SWOT・財務分析
    CSL Limited - Strategy, SWOT and Corporate Finance Report Summary CSL Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Larix AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Larix A/S (Larix) is a contract research organization that offers services related to clinical trials assistance. The organization provides services such as statistics, data management, clinical research, pharmacovigilance and data monitoring among others. It offers services across all phase …
  • ManTech International Corp (MANT):企業の財務・戦略的SWOT分析
    ManTech International Corp (MANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Power Assets Holdings Ltd (6):電力:M&Aディール及び事業提携情報
    Summary Power Assets Holdings Limited (Power Assets) a subsidiary of CK Infrastructure Holdings Limited, is an investment holding company. The company through its subsidiaries, joint ventures, and affiliates, invests in power and utility-related businesses. The company has interests in electricity g …
  • Doosan Fuel Cell America Inc:電力:M&Aディール及び事業提携情報
    Summary Doosan Fuel Cell America Inc (Doosan Fuel Cell), formerly Quantum Leap Technology Inc, a subsidiary of Doosan Corp, is a energy solution provider that manufactures and markets clean energy solutions. The company provides installation, remote monitoring and control, equipment service, financi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆